» Articles » PMID: 35011621

Clinical Features, Histopathology and Differential Diagnosis of Sarcoidosis

Abstract

Sarcoidosis is a chameleon disease of unknown etiology, characterized by the growth of non-necrotizing and non-caseating granulomas and manifesting with clinical pictures that vary on the basis of the organs that are mainly affected. Lungs and intrathoracic lymph nodes are the sites that are most often involved, but virtually no organ is spared from this disease. Histopathology is distinctive but not pathognomonic, since the findings can be found also in other granulomatous disorders. The knowledge of these findings is important because it could be helpful to differentiate sarcoidosis from the other granulomatous-related diseases. This review aims at illustrating the main clinical and histopathological findings that could help clinicians in their routine clinical practice.

Citing Articles

Unveiling the metabolomic profile of growth hormone deficiency children using NMR spectroscopy.

Aggelaki E, Giannakopoulos A, Georgiopoulou P, Chasapi S, Efthymiadou A, Kritikou D Metabolomics. 2025; 21(1):25.

PMID: 39920379 PMC: 11805833. DOI: 10.1007/s11306-024-02217-9.


Sarcoidosis: molecular mechanisms and therapeutic strategies.

Xu D, Tao X, Fan Y, Teng Y Mol Biomed. 2025; 6(1):6.

PMID: 39904950 PMC: 11794924. DOI: 10.1186/s43556-025-00244-z.


Chronic Sarcoidosis: Diagnostic Difficulties and Search for New Criteria of Inflammatory Activity (A Case Report and Literature Review).

Starshinova A, Berg E, Rubinstein A, Kulpina A, Kudryavtsev I, Kudlay D J Clin Med. 2024; 13(22).

PMID: 39598118 PMC: 11594891. DOI: 10.3390/jcm13226974.


Sarcoid-Like Reactions in Breast Cancer Patients: A Report of Two Cases.

Marinos N, Visvikis M, Georgakopoulou V, Drakopanagiotakis F, Steiropoulos P Cureus. 2024; 16(7):e64096.

PMID: 39114256 PMC: 11305606. DOI: 10.7759/cureus.64096.


A case of cutaneous sarcoidosis with pulmonary involvement after SARS-CoV-2 mRNA vaccination.

Seol J, Jang S, Yun H, Ahn S, Kim H JAAD Case Rep. 2024; 50:47-50.

PMID: 39040979 PMC: 11260821. DOI: 10.1016/j.jdcr.2024.05.019.


References
1.
Griffith D, Aksamit T, Brown-Elliott B, Catanzaro A, Daley C, Gordin F . An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007; 175(4):367-416. DOI: 10.1164/rccm.200604-571ST. View

2.
Tana C, Wegener S, Borys E, Pambuccian S, Tchernev G, Tana M . Challenges in the diagnosis and treatment of neurosarcoidosis. Ann Med. 2015; 47(7):576-91. DOI: 10.3109/07853890.2015.1093164. View

3.
Tana C, Iannetti G, Mezzetti A, Schiavone C . Splenic sarcoidosis remains a diagnostic challenge. J Clin Ultrasound. 2014; 42(3):156. DOI: 10.1002/jcu.22131. View

4.
Rafferty P, Biggs B, Crompton G, GRANT I . What happens to patients with pulmonary aspergilloma? Analysis of 23 cases. Thorax. 1983; 38(8):579-83. PMC: 459614. DOI: 10.1136/thx.38.8.579. View

5.
Arar O, Boni F, Meschi T, Tana C . Pulmonary Sarcoidosis Presenting with Miliary Opacities. Curr Med Imaging Rev. 2020; 15(1):81-83. DOI: 10.2174/1573405614666180806141415. View